Wild-type Meso-1 cells and ACTL6A knockout cells (Meso1-ACtL6A-KOc1-5-1) cells were injected into immunocompromised mice to monitor the impact of ACTL6A loss on tumor formation. Here, ACTL6A is linked to neoplasm.